SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-037907
Filing Date
2020-11-18
Accepted
2020-11-18 13:25:18
Documents
14
Period of Report
2020-11-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea130145-8k_cormedixinc.htm   iXBRL 8-K 32905
2 PRESS RELEASE DATED NOVEMBER 18, 2020 ea130145ex99-1_cormedix.htm EX-99.1 10180
3 GRAPHIC ex99-1_001.jpg GRAPHIC 14533
  Complete submission text file 0001213900-20-037907.txt   241110

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE crmd-20201118.xsd EX-101.SCH 3185
5 XBRL LABEL FILE crmd-20201118_lab.xml EX-101.LAB 34581
6 XBRL PRESENTATION FILE crmd-20201118_pre.xml EX-101.PRE 22706
7 EXTRACTED XBRL INSTANCE DOCUMENT ea130145-8k_cormedixinc_htm.xml XML 3609
Mailing Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922
Business Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 201323945
SIC: 2834 Pharmaceutical Preparations